Despite limited performance in patients who are obese or have small tumors, HCC surveillance is routinely based on ultrasound and only a few guidelines recommend additional determination of serum alpha-fetoprotein (AFP) levels [4,5,6]. This evidence concerns the gene AFP and hepatocellular carcinoma.